Metabolism of β-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450

Drug Metabolism and Disposition

Volumn 26, Issue 4, 1998, Pages 313-317

  Grace, James M ^a   Aguilar, Antonio J ^b   Trotman, Kimberly M ^b   Brewer, Thomas G ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; ARTEMISININ; CHLOROQUINE; CYTOCHROME P450; DIHYDROARTEMISININ; HALOFANTRINE; MEFLOQUINE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; WR 001544; WR 240309; WR 253997; WR 255131;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL;

ANTIMALARIALS; ARTEMISININS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MICROSOMES, LIVER; SESQUITERPENES;

PLASMODIUM FALCIPARUM;

EID: 0031953576     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baker JK, Yarber RH, Hufford CD, Lee IS, El Sohly HN and McChesney JD (1989) Thermospray mass spectroscopy/high performance liquid chromatographic identification of the metabolites formed from arteether using a rat liver microsome preparation. Biomed Environ Mass Spectrom 18:337-351.
2. Bangchang KN, Karbwang J and Back, DJ (1992) Mefloquine metabolism by human liver microsomes: Effect of other antimalarial drugs. Biochem Pharmacol 43:1957-1961.
3. Brewer TG, Petras JM, Peggins JO, Li Q, Lin AJ, Sperry M, Figueroa L, Aguilar A and Schuster BS (1993) Differential neurotoxicity of artemisinin analogs in an in vivo model. Am J Trop Med Hyg 49:292.
4. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH and Schuster BG (1994a) Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51:251-259.
5. Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH and Schuster BG (1994b) Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg. 88:33-36.
6. Chi HT, Ramu K, Baker JK, Hufford CD, Lee IS, Zeng YL and McChesney JD (1991) Identification of the in vivo metabolites of the antimalarial arteether by thermospray high-performance liquid chromatography/mass spectrometry. Biol Mass Spectrom 20:609-628.
7. Data JL, Wilkinson GR and Nies AS (1976) Interaction of quinidine with anticonvulsant drugs. N Engl J Med 294:699-702.
8. Guengerich FP, Muller-Enoch D and Blair I (1986) Oxidation of quinidine by human liver cytochrome P-450. Mal Pharmacol 30:287-295.
9. Halliday RC, Jones BC, Smith DA, Kitteringham NR and Park BK (1995) An investigation of the interaction between halofantrine. CYP2D6 and CYP3A4: Studies with human liver microsomes and heterologous enzyme expression systems. Br J Clin Pharmacol 40:369-378.
10. Hellgren U, Angel VH, Bergqvist Y, Forero-Gomez JS and Rombo L (1991) Plasma concentrations of sulfadoxine pyrimethamine, mefloquine and its main metabolite after regular malaria prophylaxis for two years. Trans R Soc Trop Med Hyg 85:356-357.
11. Hien TT and White NJ (1993) Qinghaosu. Lancet 341:603-608.
12. Klaymann DL (1985) Qinghaosu (artemisinin): An antimalarial drug from China. Science 228: 1049-1055.
13. Leskovac V and Theoharides AD (1991a) Hepatic metabolism of artemisinin drugs: I. Drug metabolism in rat liver microsomes. Comp Biochem Physiol 99C:383-390.
14. Leskovac V and Theoharides AD (1991b) Hepatic metabolism of artemisinin drugs: II. Metabolism of arteether in rat liver cytosol. Comp Biochem Physiol 99C:391-396.
15. Looareesuwan S (1994) Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 88 (Suppl 1):9-11.
16. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
17. Melendez V, Peggins JO, Brewer TG and Theoharides AD (1991) Determination of the antimalarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high-performance liquid chromatography with reductive electrochemical detection. J Pharm Sci 80:132-138.
18. Mikus G (1986) Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine. Eur J Clin Pharmacol 31:69-72.
19. Miller LG and Panosian CB (1997) Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med 336:1328.
20. Murray CJ and Lopez AD (1994) Global and regional cause-of-death patterns in 1990. Bull World Health Organ 72:447-480.
21. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K and Neben DW (1993) The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1-51.
22. Olliaro P, Cattani J and Wirth D (1996) Malaria, the submerged disease. JAMA 275:230-233.
23. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes: I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
24. Peggins JO, Brewer TG, Bley JA, Fleckenstein LL, Theoharides AD, Melendez V and Digiovanni J (1990) Pharmacokinetics and metabolism of arteether in beagles and rats after i.v. and i.m. administration. (Abstract). Symposium on Artemisinin in the Treatment of Malaria, 39th Annual Meeting of the American Society of Tropical Medicine and Hygiene, New Orleans, LA, November 1990.
25. Senanayake N and de Silva H (1994) Delayed cerebellar ataxia complicating falciparum malaria: A clinical study of 74 patients. J Neural 241:456-459.
26. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
27. Shwe T, Myint PT, Htut Y, Myint W and Soe L (1988) The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria. Trans R Soc Trop Med Hyg 82:665-666.
28. Sonderfan AJ, Arlotto MP, Dutton DR, McMillen SK and Parkinson A (1987) Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys 255:27-41.
29. Teja-Isavadharm P, Nosten F, Kyle D, Luxemburger C, Ter Kuile F, Peggins JO, Brewer TG and White NJ (1996) Comparative bioavailability of oral, rectal and intramuscular artemether in healthy subjects: Use of simultaneous measurement by high performance liquid chromatography and bioassay. Brit J Clin Pharmacol 42:599-604.
30. Twum-Barima Y and Carruthers SG (1981) Quinidine-rifampin interaction. N Engl J Med 304:1466-1469.
31. van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, Enwere G, Forck S, Nusmeijer A, Bennett S, Greenwood, B and Kwiatkowski D (1996) A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335:69-75.
32. Verme CN, Ludden TM, Clementi WA and Harris SC (1992) Pharmacokinetics of quinidine in male patients: A population analysts. Clin Pharmacokinet 22:468-480.
33. Wang PP, Beaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D and Guengerich FP (1983) Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22:5375-5383.
34. Wesche DL, DeCoster MA, Tortella FC and Brewer TG (1994) Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother 38:1813-1819.
35. White NJ (1985) Clinical pharmacokinetics of antimalarial drugs Clin Pharmacokinet 10:187-215.
36. White NJ (1996) The treatment of malaria. N Engl J Med 335:800-806.
37. Wrighton SA, Ring BJ, Watkins PB and VandenBranden M (1989) Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol Pharmacol 36:97-105.
38. Wrighton SA, Brian WR, Marie-Anges S, Iwasaki M, Guengerich FP, Raucy IL, Molowa DT and VandenBranden M (1990) Studies on the expression and metabolic capabilities of human liver capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213.
39. Zannoni D (1985) Mefloquine: An antimalarial drug interacting with the b/c region of bacterial respiratory chains. FEBS Lett 183:340-344.
40. Zucker JR and Campbell CC (1993) Malaria: Principles of prevention and treatment Infect Dis Clin North Am 7:547-566.